US Drug Recall Register
Class II · Moderate risk Terminated Initiated Jan 16, 2023 (4 years ago)

Allopurinol Tablets 100mg

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Presence of Foreign Substance: manufacturer recalled this re-packaged product due to reports of a small piece of green plastic embedded in the crack towards the edge of the tablet.

What was recalled

Allopurinol Tablets 100mg, USP, 90-count bottles, Rx Only, 90, Mfg: Accord Healthcare, Inc; Durham, NC, PREFERRED Pharmaceuticals, Inc., The Physician's Solution, Prod#: 68788-7383-09.

Recalling firm
Preferred Pharmaceuticals, Inc.
Origin
CA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0173-2023

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Allopurinol recalls

See all
Class II · Moderate risk Terminated

Allopurinol Tablets

Reason Presence of foreign substance.

Dr. Reddy's Laboratories, Inc. NDC 55111-730-01 D-0583-2024
Class II · Moderate risk Terminated

Allopurinol Tablets USP

Reason Presence of Foreign Substance: Presence of a small piece of green plastic embedded in the crack towards the edge of the tablet.

Accord Healthcare, Inc. NDC 16729-134-01 D-0168-2023
Class II · Moderate risk Terminated

ALLOPURINOL Tablets

Reason CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.

Cardinal Healthcare D-0164-2024
Class II · Moderate risk Terminated

Aloprim

Reason Discoloration: Out-of-specification results for appearance obtained during routine stability testing at the end of shelf-life for the parameters Appearance and Color of Solution.

Mylan Institutional LLC D-1271-2020
Class III · Low risk Terminated

Allopurinol Tablets

Reason Failed Tablet/Capsule Specifications; report of oversized and discolored tablets

Qualitest Pharmaceuticals NDC 0603-2116-28 D-1405-2015